Adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung
Prepared with OnCo (onco.cc/prep/lung-adenocarcinoma-in-situ-and-minimally-invasive/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
7 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example Invasive size on the resection specimen, Ground-glass and solid components on CT, EGFR mutation), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (all cases), which of the standard options do you recommend and why?
- 6.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 7.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
The words I may hear
- Lobectomy: Removing one lobe of the lung (the right lung has three, the left two).
Tests and results to bring
Biomarker results to ask for: Invasive size on the resection specimen (5 mm threshold), Ground-glass and solid components on CT, EGFR mutation (common in lepidic tumours; not treated at this stage).
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- All cases: Surgical resection, sublobar where the tumour is small and peripheral, with no adjuvant therapy; the parent's resectable page holds the sublobar-surgery trials. (Resectable stage I to III non-small-cell lung cancer, Lobectomy)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.